
Actively managed fund
JPM Thematics Genetic Thrps A acc GBPH
- ISIN
- LU2053353822
- Category
- Other Equity
- Minimum investment
- 35,000 GBP
How good is this fund, really?
See the rating in the appAbout JPM Thematics Genetic Thrps A acc GBPH
This JPMorgan Thematics sub-fund, launched in 2019, invests globally in companies with exposure to genetic therapies, including emerging markets. A tool called ThemeBot scans text and revenue data to find the most exposed firms, and specialist analysts review its output before positions are sized. Small companies and healthcare and biotechnology are likely to feature heavily. At least 51% of assets go into companies with positive environmental or social traits and at least 10% in sustainable investments. The hedged sterling A class reinvests income, sits in risk category 6 of 7 and has an ongoing charge of 1.02%.
Watch this fund for free Add JPM Thematics Genetic Thrps A acc GBPH to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.
Watch the fund for freeWhere to buy JPM Thematics Genetic Thrps A acc GBPH — platforms and fees
Sold on one platform we follow.
-
Hargreaves Lansdown Annual fee: 1.02%Go to Hargreaves Lansdown ↗
JPM Thematics Genetic Thrps A acc GBPH — its category
Other Equity — PowerFunds rates 2,983 funds in this category every month.
Other equity funds →Other funds
- JPM Global Equity Income C GBPH Net Inc
- JPM Global Rsrch Enh Eq Act ETF GBP HAcc
- JPM Global Rsrch Enh Eq Act ETF GBP HDis
- JPM Japan C GBP Hedged Net Acc
- JPM Japan Rsrch Enh Eq Act ETF USDHAcc
- JPM Russia A dist USD
- JPM Thematics Genetic Thrps A dist GBPH
- JPM US Equity Income C GBPH Net Inc
- JPM US Equity Income C2 GBPH Net Inc
- JPM US Research Enh Eq Act ETF £ H Dis
- JPM USRshEnhIdxEqSRIPrsAlgnActETFGBPHDis
- JPMorgan Emerg EMEA Sec Plc